Company Information

GLOBAL HEALTH LTD.

NSE : MEDANTABSE : 543654ISIN CODE : INE474Q01031Industry : Hospital & Healthcare ServicesHouse : Private
BSE1414.00-23.15 (-1.61 %)
PREV CLOSE ( ) 1437.15
OPEN PRICE ( ) 1440.30
BID PRICE (QTY) 1417.30 (8)
OFFER PRICE (QTY) 1419.95 (6)
VOLUME 8628
TODAY'S LOW / HIGH ( )1388.85 1449.00
52 WK LOW / HIGH ( )490 1513.75
NSE1419.10-19.3 (-1.34 %)
PREV CLOSE( ) 1438.40
OPEN PRICE ( ) 1449.80
BID PRICE (QTY) 1418.35 (8)
OFFER PRICE (QTY) 1419.55 (115)
VOLUME 168451
TODAY'S LOW / HIGH( ) 1390.00 1449.80
52 WK LOW / HIGH ( )490.9 1513.9
ChairmanNaresh Trehan
Managing DirectorNaresh Trehan
Company SecretaryRahul Ranjan
Nominee DirectorVenkatesh Ratnasami
Ravi Kant Jaipuria
Non Executive Independent DirectorPraveen Mahajan
Vikram Singh Mehta
Hari Shanker Bhartia
Rajan Bharti Mittal
Ravi Gupta
Whole Time DirectorPankaj Prakash Sahni
Non Independent & Non Executive DirectorSunil Sachdeva
Incorporation Year : 13-08 2004

Registered Office :

Address : Medanta- Mediclinic,E-18, Defence Colony, New Delhi,
Delhi-110024 .

Phone : 011-44114411

Email :  info@medanta.org 

Industry : Hospital & Healthcare Services

Listing : BSE,NSE

© NIRMAL BANG. All rights reserved

Designed , Developed & Content Powered by Accord Fintech Pvt. Ltd.

Open an Account
FOR AFREE *DEMAT & BROKING ACCOUNT

Please fill in the details below

Close X

(Note - You will receive a call from our sales executive)

CLOSE X

RISK DISCLOSURES ON DERIVATIVES

  • 9 out of 10 individual traders in equity Futures and Options Segment, incurred net losses.
  • On an average, loss makers registered net trading loss close to ₹ 50,000.
  • Over and above the net trading losses incurred, loss makers expended an additional 28% of net trading losses as transaction costs.
  • Those making net trading profits, incurred between 15% to 50% of such profits as transaction cost.

Source:

1. SEBI study dated January 25, 2023 on “Analysis of Profit and Loss of Individual Traders dealing in equity Futures and Options (F&O) Segment”, wherein Aggregate Level findings are based on annual Profit/Loss incurred by individual traders in equity F&O during FY 2021-22.